DE69426304T2 - Methoden zur regulation der den magen und darm betreffenden motilitaet - Google Patents
Methoden zur regulation der den magen und darm betreffenden motilitaetInfo
- Publication number
- DE69426304T2 DE69426304T2 DE69426304T DE69426304T DE69426304T2 DE 69426304 T2 DE69426304 T2 DE 69426304T2 DE 69426304 T DE69426304 T DE 69426304T DE 69426304 T DE69426304 T DE 69426304T DE 69426304 T2 DE69426304 T2 DE 69426304T2
- Authority
- DE
- Germany
- Prior art keywords
- methods
- stomach
- regulation
- bowel motility
- gastric emptying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11838193A | 1993-09-07 | 1993-09-07 | |
PCT/US1994/010225 WO1995007098A1 (en) | 1993-09-07 | 1994-09-07 | Methods for regulating gastrointestinal motility |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69426304D1 DE69426304D1 (de) | 2000-12-21 |
DE69426304T2 true DE69426304T2 (de) | 2001-03-15 |
Family
ID=22378228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69426304T Expired - Lifetime DE69426304T2 (de) | 1993-09-07 | 1994-09-07 | Methoden zur regulation der den magen und darm betreffenden motilitaet |
Country Status (23)
Country | Link |
---|---|
US (4) | US6114304A (de) |
EP (1) | EP0717635B1 (de) |
JP (2) | JP3821839B2 (de) |
KR (2) | KR100391399B1 (de) |
CN (1) | CN1134110A (de) |
AT (1) | ATE197549T1 (de) |
AU (1) | AU7685894A (de) |
BG (1) | BG100463A (de) |
BR (1) | BR9407424A (de) |
CA (1) | CA2171207C (de) |
CZ (1) | CZ69596A3 (de) |
DE (1) | DE69426304T2 (de) |
DK (1) | DK0717635T3 (de) |
ES (1) | ES2154299T3 (de) |
GR (1) | GR3035387T3 (de) |
HU (1) | HUT73490A (de) |
NO (1) | NO960899L (de) |
PT (1) | PT717635E (de) |
RU (1) | RU2177331C2 (de) |
SG (1) | SG98356A1 (de) |
SK (1) | SK31496A3 (de) |
WO (1) | WO1995007098A1 (de) |
ZA (1) | ZA946881B (de) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614492A (en) * | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
US6284727B1 (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
ZA946881B (en) * | 1993-09-07 | 1995-10-30 | Amylin Pharmaceuticals Inc | Methods for treating gastrointestinal motility |
US6143718A (en) | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
CA2262647C (en) * | 1996-08-08 | 2007-12-04 | Amylin Pharmaceuticals, Inc. | Methods for regulating gastrointestinal motility |
ES2247676T3 (es) | 1997-01-07 | 2006-03-01 | Amylin Pharmaceuticals, Inc. | Uso de las exendinas y de los agonistas de las mismas para la reduccion de la ingesta alimenticia. |
US7101853B2 (en) | 1997-05-06 | 2006-09-05 | Amylin Pharmaceuticals, Inc. | Method for treating or preventing gastritis using amylin or amylin agonists |
US7910548B2 (en) * | 1997-06-06 | 2011-03-22 | Amylin Pharmaceuticals, Inc. | Methods for treating obesity |
US6936584B1 (en) | 1998-02-13 | 2005-08-30 | Amylin Pharmaceuticals, Inc. | Mixed amylin activity compounds |
JP4372345B2 (ja) | 1998-02-13 | 2009-11-25 | アミリン・ファーマシューティカルズ,インコーポレイテッド | 新規な混合アミリン活性化合物 |
DE122007000001I1 (de) | 1999-01-14 | 2007-06-28 | Amylin Pharmaceuticals Inc | Neue exendin agonist Formulierungen und deren Verabreichung |
ES2343072T3 (es) | 1999-01-14 | 2010-07-22 | Amylin Pharmaceuticals, Inc. | Exendina para la supresion del glucagon. |
US7399489B2 (en) | 1999-01-14 | 2008-07-15 | Amylin Pharmaceuticals, Inc. | Exendin analog formulations |
US6924264B1 (en) | 1999-04-30 | 2005-08-02 | Amylin Pharmaceuticals, Inc. | Modified exendins and exendin agonists |
US6528486B1 (en) | 1999-07-12 | 2003-03-04 | Zealand Pharma A/S | Peptide agonists of GLP-1 activity |
US6451806B2 (en) | 1999-09-29 | 2002-09-17 | Adolor Corporation | Methods and compositions involving opioids and antagonists thereof |
US6469030B2 (en) | 1999-11-29 | 2002-10-22 | Adolor Corporation | Methods for the treatment and prevention of ileus |
EP1261282B1 (de) | 2000-03-03 | 2013-09-25 | C. R. Bard, Inc. | Endoskopisches gewebeappositionsgerät mit mehreren absaugöffnungen |
US7220266B2 (en) | 2000-05-19 | 2007-05-22 | C. R. Bard, Inc. | Tissue capturing and suturing device and method |
US6451813B1 (en) | 2001-01-26 | 2002-09-17 | R. T. Alamo Ventures I, Llc | Treatment of gastroparesis in certain patient groups |
US20040126318A1 (en) * | 2002-09-12 | 2004-07-01 | Ehrenpreis Eli D. | Methods, formulations and kits for monitoring and diagnosing gastric emptying and gastroparesis, and formulations for determining gastrointestinal motility |
US8168233B2 (en) * | 2002-10-18 | 2012-05-01 | Amylin Pharmaceuticals, Inc. | Treatment of pancreatitis with amylin |
NZ541365A (en) * | 2002-12-27 | 2009-09-25 | Diobex Inc | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
US7655618B2 (en) * | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
WO2005021026A2 (en) * | 2003-08-29 | 2005-03-10 | Amylin Pharmaceuticals, Inc. | Methods for treating or ameliorating ghrelin-associated diseases and disorders |
RU2385878C2 (ru) * | 2004-02-11 | 2010-04-10 | Амилин Фармасьютикалз, Инк. | Пептид, обладающий свойствами амилина (варианты), и его применение (варианты) |
US7399744B2 (en) * | 2004-03-04 | 2008-07-15 | Amylin Pharmaceuticals, Inc. | Methods for affecting body composition |
US7878978B2 (en) | 2004-03-18 | 2011-02-01 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Use of relaxin to increase arterial compliance |
US8172857B2 (en) | 2004-08-27 | 2012-05-08 | Davol, Inc. | Endoscopic tissue apposition device and method of use |
US8394765B2 (en) * | 2004-11-01 | 2013-03-12 | Amylin Pharmaceuticals Llc | Methods of treating obesity with two different anti-obesity agents |
EP1814590B2 (de) | 2004-11-01 | 2013-12-11 | Amylin Pharmaceuticals, Inc. | Behandlung von fettsucht und verbundenen erkrankungen |
JP5114381B2 (ja) * | 2005-03-31 | 2013-01-09 | アミリン・ファーマシューティカルズ,インコーポレイテッド | 精神疾患および障害治療用アミリンおよびアミリンアゴニスト |
EP1996224B1 (de) | 2006-03-15 | 2012-11-07 | Novo Nordisk A/S | Mischungen aus amylin und insulin |
WO2007112069A2 (en) * | 2006-03-23 | 2007-10-04 | Amylin Pharmaceuticals, Inc. | Endothelin and endothelin receptor agonists in the treatment of metabolic diseases |
US20090181890A1 (en) * | 2006-03-31 | 2009-07-16 | Amylin Pharmaceuticals , Inc. | Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders |
EP2120985B1 (de) | 2007-02-05 | 2012-06-27 | Amylin Pharmaceuticals, Inc. | FN-38 Peptide zur Verwendung bei der Behandlung Psychotischer- und Angsterkrankungen |
BRPI0722276A2 (pt) * | 2007-11-14 | 2014-04-22 | Amylin Pharmaceuticals Inc | Métodos para tratar obesidade e doenças e distúrbios relacionados à obesidade |
EP2762150A1 (de) | 2009-03-12 | 2014-08-06 | Nordic Bioscience A/S | Behandlung von Diabetes und Stoffwechselsyndrom |
WO2010107874A2 (en) * | 2009-03-17 | 2010-09-23 | Amylin Pharmaceuticals, Inc. | Methods for affecting body composition using amylin agonists |
MX343360B (es) | 2010-04-27 | 2016-11-03 | Zealand Pharma As | Conjugados peptidicos de agonistas del receptor de glp-1 y gastrina y su uso. |
CN104144704B (zh) | 2011-11-03 | 2018-03-23 | 西兰制药公司 | Glp‑1受体激动剂肽胃泌素缀合物 |
AR091866A1 (es) | 2012-07-23 | 2015-03-04 | Zealand Pharma As | Analogos del glucagon |
TWI608013B (zh) | 2012-09-17 | 2017-12-11 | 西蘭製藥公司 | 升糖素類似物 |
US9988429B2 (en) | 2013-10-17 | 2018-06-05 | Zealand Pharma A/S | Glucagon analogues |
UA122767C2 (uk) | 2013-10-17 | 2021-01-06 | Зіленд Фарма А/С | Ацильований аналог глюкагону |
EA035688B1 (ru) | 2013-11-06 | 2020-07-27 | Зилэнд Фарма А/С | Соединения, которые представляют собой тройные агонисты глюкагона, glp-1 и gip |
CA2929459C (en) | 2013-11-06 | 2022-05-03 | Zealand Pharma A/S | Gip-glp-1 dual agonist compounds and methods |
US9656017B2 (en) | 2014-06-20 | 2017-05-23 | Howard E. Greene | Infusion delivery devices and methods |
BR112017008659A2 (pt) | 2014-10-29 | 2018-01-30 | Zealand Pharma As | ?métodos e compostos de agonista de gip? |
AU2016232218B2 (en) | 2015-03-18 | 2020-09-10 | Boehringer Ingelheim International Gmbh | Amylin analogues |
AU2016247499B2 (en) | 2015-04-16 | 2020-09-03 | Zealand Pharma A/S | Acylated glucagon analogue |
US10071140B2 (en) | 2016-09-09 | 2018-09-11 | Zealand Pharma A/S | Amylin analogues |
CN117384274A (zh) | 2016-12-09 | 2024-01-12 | 西兰制药公司 | 酰化的glp-1/glp-2双重激动剂 |
EP3562500B1 (de) | 2016-12-27 | 2023-07-19 | Adocia | Zusammensetzungen in form einer injizierbaren wässrigen lösung mit amylin, einem amylin-rezeptor-agonist oder einem amylin-analogon und einer copolyaminosäure |
IL272141B1 (en) | 2017-07-27 | 2024-03-01 | Adocia | Preparations in the form of an aqueous solution for injection containing at least human insulin A21G and suppressing glucagon activity with a meal |
FR3083085B1 (fr) | 2018-06-29 | 2020-10-02 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
WO2019115411A1 (fr) | 2017-12-07 | 2019-06-20 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
FR3083086A1 (fr) | 2018-06-29 | 2020-01-03 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
EP3740195A1 (de) | 2017-12-07 | 2020-11-25 | Adocia | Zusammensetzungen in form einer injizierbaren wässrigen lösung mit amylin, einem amylin-rezeptor-agonist oder einem amylin-analogon und einer copolyaminosäure |
MX2020005916A (es) | 2017-12-07 | 2020-10-19 | Adocia | Composiciones en forma de una solución acuosa inyectable que comprende amilina, un receptor agonista de amilina o un análogo de amilina y un copoliaminoácido. |
SG11202005319PA (en) | 2017-12-07 | 2020-07-29 | Adocia | Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a copolyamino acid |
FR3084586B1 (fr) | 2018-08-03 | 2020-11-06 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un compose amphiphile porteur de radicaux hydrophobes |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4451394A (en) * | 1982-10-25 | 1984-05-29 | American Home Products Corporation | Dodecapeptides preventing glucose and triglyceride assimilation |
US4530838A (en) * | 1983-07-08 | 1985-07-23 | The Salk Institute For Biological Studies | Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals |
US4690486A (en) * | 1985-04-29 | 1987-09-01 | Texas Instruments Incorporated | Four position interlacing apparatus |
GB8709871D0 (en) * | 1987-04-27 | 1987-06-03 | Turner R C | Peptides |
US5367052A (en) * | 1987-04-27 | 1994-11-22 | Amylin Pharmaceuticals, Inc. | Amylin peptides |
GB8720115D0 (en) * | 1987-08-26 | 1987-09-30 | Cooper G J S | Treatment of diabetes mellitus |
US5266561A (en) * | 1988-01-11 | 1993-11-30 | Amylin Pharmaceuticals, Inc. | Treatment of type 2 diabetes mellitus |
US5175145A (en) * | 1988-08-26 | 1992-12-29 | Amylin Pharmaceuticals, Inc. | Treatment of diabetes mellitus with amylin agonists |
US5166192A (en) * | 1989-05-09 | 1992-11-24 | Mathias John R | Treatment of motility disorders with a GnRH analog |
US5260275A (en) * | 1990-08-14 | 1993-11-09 | Amylin Pharmaceuticals, Inc. | Hypoglycemics |
US5187154A (en) * | 1990-12-13 | 1993-02-16 | Board Of Regents, The University Of Texas System | Diagnosis and treatment of humans with diabetes or at risk to develop diabetes |
US5264372A (en) * | 1991-03-15 | 1993-11-23 | Amylin Pharmaceuticals, Inc. | Receptor-based screening methods for amylin agonists and antagonists |
US5234906A (en) * | 1991-01-10 | 1993-08-10 | Amylin Pharmaceuticals, Inc. | Hyperglycemic compositions |
HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
ATE157010T1 (de) * | 1991-05-24 | 1997-09-15 | Amylin Pharmaceuticals Inc | Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen |
US5580953A (en) * | 1991-08-14 | 1996-12-03 | Amylin Pharmaceuticals, Inc. | Amylin antagonist peptides and uses therefor |
DE69232064T2 (de) * | 1991-11-19 | 2002-03-28 | Amylin Pharmaceuticals Inc | Peptide als Amylin-Agonisten und ihre Verwendung |
US5376638A (en) * | 1992-09-01 | 1994-12-27 | Amylin Pharmaceuticals, Inc. | Methods for treating renin-related disorders with amylin antagonists |
WO1994020116A1 (en) * | 1993-03-10 | 1994-09-15 | University Of Alabama Research Foundation | Artificial primers for glycogen synthesis |
ZA946881B (en) * | 1993-09-07 | 1995-10-30 | Amylin Pharmaceuticals Inc | Methods for treating gastrointestinal motility |
US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
-
1994
- 1994-09-07 ZA ZA946881A patent/ZA946881B/xx unknown
- 1994-09-07 CZ CZ96695A patent/CZ69596A3/cs unknown
- 1994-09-07 AT AT94927398T patent/ATE197549T1/de active
- 1994-09-07 BR BR9407424A patent/BR9407424A/pt not_active Application Discontinuation
- 1994-09-07 DE DE69426304T patent/DE69426304T2/de not_active Expired - Lifetime
- 1994-09-07 DK DK94927398T patent/DK0717635T3/da active
- 1994-09-07 KR KR1019960701160A patent/KR100391399B1/ko not_active IP Right Cessation
- 1994-09-07 CA CA2171207A patent/CA2171207C/en not_active Expired - Lifetime
- 1994-09-07 US US08/302,069 patent/US6114304A/en not_active Expired - Lifetime
- 1994-09-07 AU AU76858/94A patent/AU7685894A/en not_active Abandoned
- 1994-09-07 CN CN94193931A patent/CN1134110A/zh active Pending
- 1994-09-07 EP EP94927398A patent/EP0717635B1/de not_active Expired - Lifetime
- 1994-09-07 ES ES94927398T patent/ES2154299T3/es not_active Expired - Lifetime
- 1994-09-07 KR KR10-2003-7005868A patent/KR100429966B1/ko not_active IP Right Cessation
- 1994-09-07 SK SK314-96A patent/SK31496A3/sk unknown
- 1994-09-07 JP JP50882395A patent/JP3821839B2/ja not_active Expired - Lifetime
- 1994-09-07 RU RU96107891/14A patent/RU2177331C2/ru active
- 1994-09-07 PT PT94927398T patent/PT717635E/pt unknown
- 1994-09-07 HU HU9600558A patent/HUT73490A/hu unknown
- 1994-09-07 SG SG9607979A patent/SG98356A1/en unknown
- 1994-09-07 WO PCT/US1994/010225 patent/WO1995007098A1/en active IP Right Grant
-
1995
- 1995-06-05 US US08/471,675 patent/US5795861A/en not_active Expired - Lifetime
-
1996
- 1996-03-06 NO NO960899A patent/NO960899L/no unknown
- 1996-03-29 BG BG100463A patent/BG100463A/xx unknown
-
2000
- 2000-05-22 US US09/576,062 patent/US6608029B1/en not_active Expired - Fee Related
-
2001
- 2001-02-07 GR GR20010400214T patent/GR3035387T3/el unknown
-
2003
- 2003-08-18 US US10/643,681 patent/US7407934B2/en not_active Expired - Fee Related
-
2004
- 2004-08-11 JP JP2004234571A patent/JP2004331674A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69426304T2 (de) | Methoden zur regulation der den magen und darm betreffenden motilitaet | |
CA2262647A1 (en) | Methods for regulating gastrointestinal motility | |
EA200000445A1 (ru) | Способы лечения состояния гиперкоагуляции или приобретенной недостаточности белка c | |
NO890224L (no) | Fremgangsmaate og anordning for medisinsk behandling av den patologiske tilstand av ben. | |
DE69204162T2 (de) | Zusammensetzung auf der basis von silikon und latex zur behandlung von keratinösen substanzen. | |
AU7814498A (en) | Multivalent (in ovo) avian vaccine | |
CA2340320A1 (en) | Use of an angiogenic factor for the treatment of microascular angiopathies | |
CA2347863A1 (en) | Treatment of disorders of the outer retina | |
UA50761C2 (uk) | Спосіб запобігання та/або лікування серцевих захворювань, фармацевтична композиція та спосіб запобігання та/або лікування серцевої недостатності та дисфункції шлуночків в організмі теплокровної тварини | |
WO1999056666A8 (en) | The treatment of sexual dysfunction in certain patient groups | |
EP1417971A3 (de) | Verwendung eines angiogenen Faktors zur Behandlung von mikrovaskulären Angiopathien | |
DE3767731D1 (de) | Prostacyclinanalog, dieses als aktives bestandteil enthaltendes, den blutumlauf verbesserndes mittel und gegen magengeschwuere wirkendes mittel. | |
ATE204169T1 (de) | Polyamin-antagonisten enthaltende intraokulare irrigationslösung | |
MD686G2 (ro) | Metodă de tratament al reflux- esofagitei | |
UA32153A (uk) | Спосіб формування трансплантату для зведення на промежину при черевно-анальних резекціях прямої кишки | |
UA29280A (uk) | Спосіб лікування флегмони шлунку | |
UA31276A (uk) | Спосіб діагностики хламідіозу і мікоплазмозу у хворих на ранній сифіліс | |
UA30550A (uk) | Спосіб лікування неплідності у жінок з гіперпролактинемією | |
GEU2000631Y (en) | Method for Selective-Proximal Vagotomy | |
RU93025273A (ru) | Способ закрытия обширных дефектов кожи черепа | |
DE9417574U1 (de) | Medizinische Vorrichtung zum Einführen von medizinischen Anordnungen ect. durch Gewebeschichten in den Körper | |
UA22088A (uk) | Спосіб hакладаhhя дуодеhостоми | |
MX9605053A (es) | Proceso de micelizacion de nutrientes para ser absorbidos por el cuerpo humano. | |
UA10150A (uk) | Спосіб хірургічного лікування низькорозташованих невидалимих виразок дванадцятипалої кишки | |
UA34378A (uk) | Спосіб лікування перелому надколінника |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |